Brief: BioLife Solutions Q1 Revenue USD 16.2 Million Vs. IBES Estimate USD 26 Million
May 09 (Reuters) - BioLife Solutions Q1 gross margin 38%. * Q1 net income USD -10.2 million * Q1 adjusted gross margin 40% * Q1 adjusted operating income USD -9.1 million vs. IBES estimate USD -12.3 million * Q1 adjusted net income USD -9 million vs. IBES estimate USD -12.5 million * Q1 operating income USD -10.1 million * outlook FY revenue USD 95.5-100 million
Recent news on BioLife Solutions
See all newsFreshworks gains ahead of S&P SmallCap 600 inclusion
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Freshworks Set To Join S&P Smallcap 600
BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary